These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 24872147)

  • 21. Pharmacokinetics and safety of fluconazole and micafungin in neonates with systemic candidiasis: a randomized, open-label clinical trial.
    Leroux S; Jacqz-Aigrain E; Elie V; Legrand F; Barin-Le Guellec C; Aurich B; Biran V; Dusang B; Goudjil S; Coopman S; Garcia Sanchez R; Zhao W; Manzoni P;
    Br J Clin Pharmacol; 2018 Sep; 84(9):1989-1999. PubMed ID: 29744900
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Old and new: appropriate dosing for neonatal antifungal drugs in the nursery.
    Ericson J; Manzoni P; Benjamin DK
    Early Hum Dev; 2013 Jun; 89 Suppl 1(0 1):S25-7. PubMed ID: 23809344
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recent advances in antifungal chemotherapy.
    Petrikkos G; Skiada A
    Int J Antimicrob Agents; 2007 Aug; 30(2):108-17. PubMed ID: 17524625
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of extracorporeal membrane oxygenation on antifungal pharmacokinetics: A systematic review.
    Jendoubi A; Pressiat C; De Roux Q; Hulin A; Ghaleh B; Tissier R; Kohlhauer M; Mongardon N
    Int J Antimicrob Agents; 2024 Feb; 63(2):107078. PubMed ID: 38161046
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Population pharmacokinetics of fluconazole in young infants.
    Wade KC; Wu D; Kaufman DA; Ward RM; Benjamin DK; Sullivan JE; Ramey N; Jayaraman B; Hoppu K; Adamson PC; Gastonguay MR; Barrett JS;
    Antimicrob Agents Chemother; 2008 Nov; 52(11):4043-9. PubMed ID: 18809946
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antifungal therapy in infants and children with proven, probable or suspected invasive fungal infections.
    Blyth CC; Hale K; Palasanthiran P; O'Brien T; Bennett MH
    Cochrane Database Syst Rev; 2010 Feb; 2010(2):CD006343. PubMed ID: 20166083
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Innovative antifungals for treatment of invasive fungal infections].
    Glöckner A
    Internist (Berl); 2011 Sep; 52(9):1118-24, 1126. PubMed ID: 21744150
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exposure-Response Analysis of Micafungin in Neonatal Candidiasis: Pooled Analysis of Two Clinical Trials.
    Kovanda LL; Walsh TJ; Benjamin DK; Arrieta A; Kaufman DA; Smith PB; Manzoni P; Desai AV; Kaibara A; Bonate PL; Hope WW
    Pediatr Infect Dis J; 2018 Jun; 37(6):580-585. PubMed ID: 29762386
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pharmacodynamics and pharmacokinetics of micafungin in adults, children and neonate].
    Catalán-González M; Carlos Montejo-González J
    Rev Iberoam Micol; 2009 Mar; 26(1):23-34. PubMed ID: 19463274
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antifungal pharmacodynamics: review of the literature and clinical applications.
    Dodds ES; Drew RH; Perfect JR
    Pharmacotherapy; 2000 Nov; 20(11):1335-55. PubMed ID: 11079283
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antifungal pharmacotherapy for neonatal candidiasis.
    Bliss JM; Wellington M; Gigliotti F
    Semin Perinatol; 2003 Oct; 27(5):365-74. PubMed ID: 14626500
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Echinocandins: the newest class of antifungals.
    Sucher AJ; Chahine EB; Balcer HE
    Ann Pharmacother; 2009 Oct; 43(10):1647-57. PubMed ID: 19724014
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intravenous Antibiotic and Antifungal Agent Pharmacokinetic-Pharmacodynamic Dosing in Adults with Severe Burn Injury.
    Cota JM; FakhriRavari A; Rowan MP; Chung KK; Murray CK; Akers KS
    Clin Ther; 2016 Sep; 38(9):2016-31. PubMed ID: 27586127
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Echinocandin use in the neonatal intensive care unit.
    Caudle KE; Inger AG; Butler DR; Rogers PD
    Ann Pharmacother; 2012 Jan; 46(1):108-16. PubMed ID: 22190252
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Micafungin antifungal prophylaxis in children undergoing HSCT: can we give higher doses, less frequently? A pharmacokinetic study.
    Chandra S; Fukuda T; Mizuno K; Davies SM; Teusink-Cross A; Tarin R; Marsh RA; Vinks AA; Mehta PA
    J Antimicrob Chemother; 2018 Jun; 73(6):1651-1658. PubMed ID: 29481593
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The management of Candida infections in preterm neonates and the role of micafungin.
    Manzoni P; Benjamin DK; Hope W; Rizzollo S; Del Sordo P; Stronati M; Jacqz-Aigrain E; Castagnola E; Farina D
    J Matern Fetal Neonatal Med; 2011 Oct; 24 Suppl 2():24-7. PubMed ID: 21749182
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetic, efficacy, and safety considerations for the use of antifungal drugs in the neonatal population.
    Scott BL; Hornik CD; Zimmerman K
    Expert Opin Drug Metab Toxicol; 2020 Jul; 16(7):605-616. PubMed ID: 32508205
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics and pharmacodynamics of antifungals.
    Andes D
    Infect Dis Clin North Am; 2006 Sep; 20(3):679-97. PubMed ID: 16984875
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of caspofungin or micafungin as empiric antifungal therapy in adult patients with persistent febrile neutropenia: a retrospective, observational, sequential cohort analysis.
    Kubiak DW; Bryar JM; McDonnell AM; Delgado-Flores JO; Mui E; Baden LR; Marty FM
    Clin Ther; 2010 Apr; 32(4):637-48. PubMed ID: 20435233
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antifungal pharmacodynamics: Latin America's perspective.
    Gonzalez JM; Rodriguez CA; Agudelo M; Zuluaga AF; Vesga O
    Braz J Infect Dis; 2017; 21(1):79-87. PubMed ID: 27821250
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.